Despite the scarcity of high quality cancer registries and lack of reliable mortality data, it is
clear that human papillomavirus (HPV)-associated diseases, particularly cervical cancer, are …

Objectives To identify the gaps of knowledge and highlight the challenges and opportunities
for controlling cervical cancer in sub‐Saharan Africa (SSA). Methods A comprehensive …

Cervical cancer is a critical public health issue in sub-Saharan Africa (SSA), where it is the
second leading cause of cancer among women and the leading cause of female cancer …

Introduction: Infections caused by high-risk human papillomavirus (HPV) are responsible for
7.7% of cancers in developing countries, mainly cervical cancer. This disease is steadily …

The availability of both human papillomavirus (HPV) vaccination and alternative screening
tests has greatly improved the prospects of cervical cancer prevention in sub-Saharan …

Infection with human papillomavirus (HPV) is recognized as one of the major causes of
infection-related cancer worldwide, as well as the causal factor in other diseases. Strong …

Background Human papillomavirus (HPV), one of the most common sexually transmitted
viral infections worldwide, is the leading cause of cervical cancer. In Middle East and North …

The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

This article reports on qualitative research investigating key challenges and barriers towards
human papillomavirus (HPV) vaccine introduction in the Western Cape Province, South …

The objectives of the study were to investigate prevalence of cervical human papillomavirus
(HPV) genotypes to inform HPV vaccination strategy in South Africa and to study factors …